Sat, Oct 25, 2014, 12:24 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rosemariecorbin rosemariecorbin Feb 7, 2012 6:37 AM Flag

    Fridays news

    guess that no reaction but the data is compelling and the report later this year will be another big success for GHDX

    trials
    Separately, Genomic Health has initiated a clinical validation study for its prostate cancer test and plans to announce topline results later this year. The ongoing clinical validation study, being performed in collaboration with leading prostate cancer researchers at the University of California, San Francisco (UCSF), is designed to determine if a multi-gene test can help patients with early stage prostate cancer by distinguishing aggressive disease requiring immediate treatment, such as surgery, from indolent disease which may be appropriately managed with active surveillance.

 
GHDX
33.65+0.57(+1.72%)Oct 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
SodaStream International Ltd.
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT
Digital River Inc.
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT
Deckers Outdoor Corp.
NYSEFri, Oct 24, 2014 4:01 PM EDT